A recent SCOTUS ruling on a healthcare fraud case could help defend labs against baseless whistleblower cases.
Ruling could spell good news for labs and other healthcare providers targeted by whistleblowers in False Claims Act qui tam lawsuits.
Recent cases involve COVID-19 fraud, UDTs, and the latest HIPAA Right of Access settlement.
Last week’s three key cases included two involving drug testing that was either medically unnecessary, or not provided at all.
Two companies settle kickback and FCA-related claims, a qui tam case is tossed, and a lab tech loses a workplace harassment case.